Yahoo Malaysia Web Search

Sign In

Search results

  1. www.thestar.com.my › business › business-newsPharmaniaga says 'stands firm' on financial recovery to exit PN17

    May 10, 2024 · KUALA LUMPUR: Pharmaniaga Bhd said it "stands firm with its commitment to financial recovery amidst the opinion of its independent auditor PricewaterhouseCoopers (PWC) on the group’s 2023 financial statement, dated March 29, 2023.”

  2. theedgemalaysia.com › article › cover-story-pharmaniaga-readying-2024-liftoffCover Story: Pharmaniaga readying for a 2024 lift-off - The Edge...

    Mar 31, 2022 · Pharmaniaga, the country’s largest listed pharmaceutical comp... HAVING experienced its most profit­able year in 2021, Pharmaniaga Bhd would be justified in heading into 2022 with confidence. Yet, its group managing director Datuk Zulkarnain Md Eusope says it is taking nothing for granted.

  3. www.thestar.com.my › business › business-newsPharmaniaga reports narrower loss for FY23 on restructuring...

    Feb 29, 2024 · KUALA LUMPUR: Pharmaniaga Bhd’s net loss for the financial year ended Dec 31, 2023 (FY2023) narrowed to RM77.45 million from RM629.92 million in FY2022.

  4. pharmaniaga.comPharmaniaga

    Feb 23, 2024 · LATEST. News Updates. 5 JUNE 2024. PHARMANIAGA RE-EMERGES STRONGER AFTER A YEAR OF CHALLENGES. Pharmaniaga Berhad (Pharmaniaga) will continue to leverage on improving operational efficiency and stringent cost control measures that has proven to have helped the Group to be resilient and re-emerged stronger amidst its challenging financial situation.

  5. www.malaymail.com › news › moneyPharmaniaga says ‘stands firm’ on financial recovery to exit PN17

    May 10, 2024 · KUALA LUMPUR, May 10 — Pharmaniaga Bhd said it “stands firm with its commitment to financial recovery amidst the opinion of its independent auditor PricewaterhouseCoopers (PWC) on the group’s 2023 financial statement, dated March 29, 2023”.

  6. www.nst.com.my › business › 2023/07/935341Pharmaniaga sees 'clear' plan by end of the year

    Yesterday, Pharmaniaga's subsidiary Pharmaniaga LifeScience Sdn Bhd (PLS) inked a memorandum of understanding (MoU) with CSPC Ouyi Pharmaceutical Co. Ltd. to enhance the production of CSPC's biopharmaceutical portfolio, focusing on its advanced mRNA vaccines over the next two years.

  7. www.thestar.com.my › business › business-newsPharmaniaga likely to see earnings growth in FY24 | The Star

    Dec 6, 2023 · PETALING JAYA: Pharmaniaga Bhd is expected to see earnings growth in its financial year ending Dec 31, 2024 (FY24), reaching pre-Covid levels and averaging between RM40mil and RM60mil.

  8. theedgemalaysia.com › node › 656995Massive RM552.3 million vaccine provision pulls Pharmaniaga into...

    Feb 27, 2023 · KUALA LUMPUR (Feb 27): Pharmaniaga Bhd announced its largest ever quarterly net loss of RM664.39 million, or 49.19 sen per share, in the fourth quarter ended Dec 31, 2022 (4QFY2022) as a result of RM552.3 million of impairment of Covid-19 vaccines.

  9. www.nst.com.my › business › corporatePharmaniaga's Q1 net profit jumps almost nine fold on better...

    May 27, 2024 · KUALA LUMPUR: Pharmaniaga Bhd's first quarter ended Mar 31, 2024 (Q1 2024) net profit increased almost nine-fold to RM25.65 million from RM2.65 million a year ago, on higher sales from government hospitals and it's Indonesia business.

  10. themalaysianreserve.com › 2023/05/18Pharmaniaga overcomes challenges, shows resilience with positive...

    May 18, 2023 · Pharmaniaga Bhd posted a net profit of RM2.64 million in the first quarter of fiscal year 2023 (1Q23), rebounding from a net loss of RM644.4 million in the preceding quarter. To re-cap, Pharmaniaga’s Q422 turned to red as a result of RM552.3 million of impairment of Covid-19 vaccines.